Structure

InChI Key CBVCZFGXHXORBI-PXQQMZJSSA-N
Smile CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O
InChI
InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C36H47N5O4
Molecular Weight 613.8
AlogP 2.87
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 11.0
Polar Surface Area 118.03
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 45.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
HIV Infections 3 D015658 ClinicalTrials
Acquired Immunodeficiency Syndrome 3 D000163 ClinicalTrials
Sarcoma, Kaposi 2 D012514 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 150378-17-9
ChEBI 44032
ChEMBL CHEMBL115
DrugBank DB00224
DrugCentral 1437
EPA CompTox DTXSID4043802
FDA SRS 9MG78X43ZT
Human Metabolome Database HMDB0014369
KEGG C07051
PDB MK1
PharmGKB PA449977
PubChem 5484730
SureChEMBL SCHEMBL6317
ZINC ZINC000022448696